Genetic correction of serum AFP level improves risk prediction of primary hepatocellular carcinoma in the Dongfeng–Tongji cohort study

Serum alpha‐fetoprotein (AFP) is the most commonly used tumor biomarker for screening and diagnosis of primary hepatocellular carcinoma (HCC). However, the predictive effect for HCC risk is still unsatisfactory. The aim of this prospective study was to estimate whether the individual genetic correct...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ke, Bai, Yansen, Chen, Shi, Huang, Jiao, Yuan, Jing, Chen, Weihong, Yao, Ping, Miao, Xiaoping, Wang, Youjie, Liang, Yuan, Zhang, Xiaomin, He, Meian, Yang, Handong, Guo, Huan, Wei, Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Cancer Prevention
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6010894/
https://www.ncbi.nlm.nih.gov/pubmed/29696820
http://dx.doi.org/10.1002/cam4.1481

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6010894/
https://www.ncbi.nlm.nih.gov/pubmed/29696820
http://dx.doi.org/10.1002/cam4.1481

Ejemplares similares